Effect of WBC BRCA1 promoter methylation on ovarian cancer risk

被引:0
|
作者
Lonning, P. E.
Bjornslett, M.
Knappskog, S.
Vatten, L.
Romundstad, P.
Axcrona, U.
Evans, D. G.
Howell, A.
Dorum, A.
Chrisanthar, R.
机构
[1] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway
[2] Haukeland Hosp, Inst Med, N-5021 Bergen, Norway
[3] Univ Oslo, Dept Med Genet, Oslo, Norway
[4] Univ Bergen, Inst Med, Sect Oncol, Bergen, Norway
[5] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway
[6] Univ Trondheim, Dept Publ Hlth, Trondheim, Norway
[7] Oslo Univ Hosp, Dept Pathol, Oslo, Norway
[8] St Marys Hosp, Manchester M13 0JH, Lancs, England
[9] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[10] Oslo Univ Hosp, Radiumhosp, Dept Gynecol Oncol, Oslo, Norway
[11] Oslo Univ Hosp, Radiumhosp, Inst Clin Med, Oslo, Norway
[12] Univ Bergen, Inst Med, Bergen, Norway
关键词
D O I
10.1200/jco.2011.29.15_suppl.5029
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5029
引用
收藏
页数:1
相关论文
共 50 条
  • [41] DNA Methylation and microRNA patterns are in association with the expression of BRCA1 in ovarian cancer
    Shariati-Kohbanani, M.
    Zare-Bidaki, M.
    Taghavi, M. M.
    Taghipour, Z.
    Shabanizadeh, A.
    Kennedy, D.
    Dahim, H.
    Salahshoor, M. R.
    Jalili, C.
    Arababadi, M. Kazemi
    [J]. CELLULAR AND MOLECULAR BIOLOGY, 2016, 62 (01) : 16 - 23
  • [42] A critical re-appraisal of BRCA1 methylation studies in ovarian cancer
    Senturk, Emir
    Cohen, Samantha
    Dottino, Peter R.
    Martignetti, John A.
    [J]. GYNECOLOGIC ONCOLOGY, 2010, 119 (02) : 376 - 383
  • [43] Epigenetic inactivation of BRCA1 through promoter hypermethylation in ovarian cancer progression
    Wang, Yan-Qiu
    Yan, Qin
    Zhang, Jia-Rong
    Li, Shuang-Di
    Yang, Yi-Xia
    Wan, Xiao-Ping
    [J]. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2013, 39 (02) : 549 - 554
  • [44] The BRCA1 Methylation and PD-L1 Expression in Sporadic Ovarian Cancer
    Zhu, Xinxin
    Zhao, Ling
    Lang, Jinghe
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 (08) : 1514 - 1519
  • [45] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    [J]. HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [46] The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
    Metcalfe, KA
    Lynch, HT
    Ghadirian, P
    Tung, N
    Olivotto, IA
    Foulkes, WD
    Warner, E
    Olopade, O
    Eisen, A
    Weber, B
    McLennan, J
    Sun, P
    Narod, SA
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (01) : 222 - 226
  • [47] Monozygotic twins discordant for constitutive BRCA1 promoter methylation, childhood cancer and secondary cancer
    Galetzka, Danuta
    Hansmann, Tamara
    El Hajj, Nady
    Weis, Eva
    Irmscher, Benjamin
    Ludwig, Marco
    Schneider-Raetzke, Brigitte
    Kohlschmidt, Nicolai
    Beyer, Vera
    Bartsch, Oliver
    Zechner, Ulrich
    Spix, Claudia
    Haaf, Thomas
    [J]. EPIGENETICS, 2012, 7 (01) : 47 - 54
  • [48] BRCA1 gene promoter methylation in metaplastic breast carcinomas
    Reis Filho, J. S.
    Turner, N.
    Schmitt, F. C.
    Tutt, A.
    Ashworth, A.
    [J]. JOURNAL OF PATHOLOGY, 2006, 210 : 59 - 59
  • [49] Functional analysis of CpG methylation in the BRCA1 promoter region
    Debora N Mancini DiNardo
    Darci T Butcher
    Dale P Robinson
    Trevor K Archer
    David I Rodenhiser
    [J]. Oncogene, 2001, 20 : 5331 - 5340
  • [50] Functional analysis of CpG methylation in the BRCA1 promoter region
    DiNardo, DNM
    Butcher, DT
    Robinson, DP
    Archer, TK
    Rodenhiser, DI
    [J]. ONCOGENE, 2001, 20 (38) : 5331 - 5340